greeksoup/ stock research

Relay Therapeutics, Inc. 13F holders

259 funds reported a position in Relay Therapeutics, Inc. in their 13F for the quarter ended 30 June 2026, together 246.8 million shares worth $4.58 billion. Against the quarter before, 48 opened a position, 113 added, 62 trimmed and 31 sold out; together they bought a net 61.8 million shares. The largest holders: SB Investment Advisers (uk) Ltd, FMR LLC and Casdin Capital, LLC.

Funds holding259+15 on Q1 2026
Shares they held246.8Mworth $4.58 billion
Net bought on the quarter61.8M sharesabout $1.15 billion at the funds' values
Funds buying to selling161 to 93opened or added, to cut or sold
Opened 48Added 113Held 34Trimmed 62Sold out 31
Opened: 48 fundsAdded: 113 fundsHeld: 34 fundsTrimmed: 62 fundsSold out: 31 funds

What each fund did in RLAY against its 13F for the quarter before; a change under 0.1% of a holding counts as held

Q3 2024: 195 funds, 169.4 million shares195Q3 2024Q4 2024: 199 funds, 163.9 million shares199Q4 2024Q1 2025: 207 funds, 167.3 million shares207Q1 2025Q2 2025: 208 funds, 171.4 million shares208Q2 2025Q3 2025: 199 funds, 166.6 million shares199Q3 2025Q4 2025: 227 funds, 174.1 million shares227Q4 2025Q1 2026: 244 funds, 185.1 million shares244Q1 2026Q2 2026: 259 funds, 246.8 million shares259Q2 2026

Funds reporting a position in RLAY in their 13F, each quarter; hover a bar for the shares they held

Filed so far for the quarter to 30 September 2026

2,671 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 28 reported a position in Relay Therapeutics, Inc.: 4 opened one, 8 added, 4 trimmed and 1 sold out, a net 249,745 shares bought.

The largest moves in the name among the funds that have filed, against each fund's previous 13F.

The well-known funds

Of the 44 funds followed here, 7 reported a position in Relay Therapeutics, Inc. in a 13F for the quarter ended 30 June 2026. The largest: FMR LLC, 20.1 million shares worth $376.3 million, 0.0% of its reported book. New this quarter: Duquesne Family Office. In the quarter, 5 funds added or opened a position and 2 trimmed or sold out; together they bought a net 17.4 million shares, about $325.0 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.

FundSharesValueOf its bookChange on the quarterStatusQuarter endedFiling
FMR LLC20,110,113$376.3 million0.0%+16,414,682added30 June 202613F
Geode Capital Management4,726,576$88.4 million0.0%+1,215,940added30 June 202613F
Two Sigma Investments700,921$13.1 million0.0%-668,228trimmed30 June 202613F
Millennium Management591,675$11.1 million0.0%+243,942added30 June 202613F
Citadel Advisors473,682$8.9 million0.0%+297,417added30 June 202613F
Duquesne Family Office349,000$6.5 million0.1%+349,000new30 June 202613F
Renaissance Technologies192,399$3.6 million0.0%-481,200trimmed30 June 202613F
Value is what the fund reported.
Read moreChange is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.

The largest holders

FundSharesShare of allValueOf its bookChange in sharesFiling
SB Investment Advisers (uk) Ltd27,904,96311.31%$522.1 million6.81%no change13F
FMR LLC20,110,1138.15%$376.3 million0.02%+16,414,68213F
Casdin Capital, LLC16,035,2406.50%$300.0 million15.02%+1,616,66613F
BlackRock, Inc.15,288,2026.19%$286.0 million0.00%+2,312,90313F
Perceptive Advisors LLC14,106,1875.72%$263.9 million4.11%+4,355,04613F
Commodore Capital LP12,000,0004.86%$224.5 million13.37%-5,000,00013F
State Street Corp.10,125,3814.10%$189.5 million0.01%+3,891,83613F
Vanguard Capital Management LLC8,964,4233.63%$167.7 million0.00%+1,576,95813F
Price T Rowe Associates Inc.7,708,5073.12%$144.2 million0.01%+5,783,56913F
Nextech Invest Ltd.6,776,5062.75%$126.8 million6.02%+1,250,00013F
Bellevue Group AG6,185,9702.51%$115.7 million2.44%-1,609,27213F
Geode Capital Management, LLC4,726,5761.92%$88.4 million0.01%+1,215,94013F
TCG Crossover Management, LLC4,273,3561.73%$80.0 million1.92%no change13F
Morgan Stanley3,851,0711.56%$72.1 million0.00%+2,419,06813F
Siren, L.L.C.3,650,0001.48%$68.3 million1.39%new13F
Goldman Sachs Group Inc.3,408,7011.38%$63.8 million0.01%+866,84013F
Westfield Capital Management Co. LP3,343,4961.35%$62.6 million0.20%new13F
Kynam Capital Management, LP3,300,0001.34%$61.7 million3.41%+1,875,74113F
Dimensional Fund Advisors LP3,127,5641.27%$58.5 million0.01%+187,02813F
Spruce Street Capital LP2,984,1251.21%$55.8 million10.95%no change13F
Vanguard Portfolio Management LLC2,892,7851.17%$54.1 million0.00%+1,029,22013F
Baker Bros. Advisors LP2,826,7831.15%$52.9 million0.27%+1,666,66613F
Bank of America Corp.2,695,1081.09%$50.4 million0.00%+757,41313F
MPM Bioimpact LLC2,415,6720.98%$45.2 million2.76%+56,08613F
Arrowstreet Capital, Limited Partnership2,238,9290.91%$41.9 million0.02%+1,570,64013F
AllianceBernstein L.P.4,095,6001.66%$40.8 million0.01%+3,950,34913F
Pictet Asset Management Holding SA2,077,2970.84%$39.2 million0.04%+2,057,70513F
Northern Trust Corp.1,953,4560.79%$36.5 million0.00%+278,06913F
T. Rowe Price Investment Management, Inc.1,915,4590.78%$35.8 million0.02%new13F
Franklin Resources Inc.1,856,9130.75%$34.7 million0.01%+1,807,99813F
Polar Capital Holdings Plc1,789,0560.72%$33.5 million0.10%new13F
Adage Capital Partners GP, L.l.c.1,740,0000.71%$32.6 million0.05%-850,00013F
Charles Schwab Investment Management Inc.1,500,8170.61%$28.1 million0.00%+388,92613F
Elmind Capital, LP1,465,2790.59%$27.4 million6.89%+928,33313F
Alphabet Inc.1,410,0290.57%$26.4 million0.03%-154,14413F
Panagora Asset Management Inc.1,291,1820.52%$24.2 million0.07%+473,14113F
AQR Capital Management LLC1,279,4730.52%$23.9 million0.01%-10,55913F
Foresite Capital Management IV, LLC1,250,0000.51%$23.4 million8.06%+250,00013F
Vanguard Fiduciary Trust Co.1,224,0060.50%$22.9 million0.01%+323,46013F
UBS Group AG1,094,9800.44%$20.5 million0.00%+567,36913F
First Trust Advisors LP1,075,1260.44%$20.1 million0.01%new13F
Affinity Asset Advisors, LLC1,050,0000.43%$19.6 million0.97%+650,00013F
Frazier Life Sciences Management, L.P.1,015,6930.41%$19.0 million0.41%new13F
Squadron Capital Management LLC970,0000.39%$18.1 million6.21%+297,50013F
Connor, Clark & Lunn Investment Management Ltd.961,7020.39%$18.0 million0.03%+124,66413F
Woodline Partners LP929,6920.38%$17.4 million0.05%+250,35013F
JPMorgan Chase & Co.801,6570.32%$16.0 million0.00%+154,13913F
Timothy G. Youngquist 2020 Irrevocable Trust801,4640.32%$15.0 million3.01%+302,40613F
Raymond James Financial Inc.783,0650.32%$14.7 million0.00%+436,74813F
Jupiter Asset Management Ltd719,5760.29%$13.5 million0.07%new13F
The 50 largest of the 259 funds that reported a position in RLAY in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read moreShare of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?

Options the funds reported on RLAY

FundOptionShares under the optionsValue of those sharesQuarter endedFiling
Citadel AdvisorsPuts561,400$10.5 million30 June 202613F
Citadel AdvisorsCalls252,000$4.7 million30 June 202613F
A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost.
Read moreThey are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.

Schedule 13D and 13G filed on the name, last twelve months

FiledScheduleWhoHoldingOf the classEvent dateRule or purposeFiling
14 August 202613G/ACommodore Capital LP and 7 others12.0 million5.5%30 June 2026passive, under 20% (13d-1(c))EDGAR
10 August 202613G/APerceptive Advisors LLC and 5 others14.1 million6.4%30 June 2026passive, under 20% (13d-1(c))EDGAR
7 August 202613G/AFMR LLC and 3 others21.3 million10.0%31 July 2026passive, institutional (13d-1(b))EDGAR
6 August 202613GFMR LLC and 3 others20.0 million9.4%30 June 2026passive, institutional (13d-1(b))EDGAR
15 May 202613G/APoint72 Asset Management, L.P. and 5 others00.0%31 March 2026passive, under 20% (13d-1(c))EDGAR
13 April 202613GPerceptive Advisors LLC and 5 others438,47110.0%6 April 2026passive, under 20% (13d-1(c))EDGAR
27 March 202613G/AThe Vanguard Group and 1 other00.0%13 March 2026passive, institutional (13d-1(b))EDGAR
19 March 202613GPerceptive Advisors LLC and 5 others9.4 million5.3%12 March 2026passive, under 20% (13d-1(c))EDGAR
17 February 202613G/ACasdin Capital, LLC and 7 others13.0 million7.5%31 December 2025passive, under 20% (13d-1(c))EDGAR
17 February 202613G/ACasdin Capital, LLC and 7 others13.0 million7.5%31 December 2025passive, under 20% (13d-1(c))EDGAR
14 November 202513G/ACommodore Capital LP and 7 others17.0 million9.9%30 September 2025passive, under 20% (13d-1(c))EDGAR
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read moreAmendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13G

Fails to deliver

Settlement dateShares failedPriceFile
25 September 2026253$17.73SEC
24 September 2026984$18.03SEC
23 September 20264$19.35SEC
22 September 2026149$18.19SEC
21 September 202644,266$18.84SEC
9 September 202672,046$19.11SEC
8 September 202650$19.04SEC
4 September 202618,880$19.01SEC
31 August 2026883$18.77SEC
27 August 202618$19.46SEC
26 August 202649,014$20.57SEC
25 August 202619$19.76SEC
24 August 20267,981$19.44SEC
21 August 202630,280$19.70SEC
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read moreLargest in the window: 72,046 on 9 September 2026. A fail is an operational fact about settlement, not a position.